Extended Data Figure 7: Gene perturbation efficiency and indel mutations after CRISPR–Cas9 targeted disruption in A375 cells.
From: Identification of essential genes for cancer immunotherapy
Deep sequencing analysis of indels generated by CRISPR–Cas9 at the exonic target site of each gene validated in A375 cells at day 5 after transduction. Average values are mean. Error bars denotes s.e.m.
